Administration of aromatase inhibitors or deletion of aromatase increased ischemic damage in experimental stroke models beyond what was seen in ovariectomized mice, suggesting that endogenous extragonadal estradiol production is important in females for neuroprotection [12]. The gene discussed is CYP19A1; the disease is Stroke.